News for GT Biopharma, Inc. (GTBP)

Published at

Mar 4, 2025 1:00 PM

by gurufocus.com

neutral

neutral

GT Biopharma to Participate in the 10th Anniversary of the Innate Killer Summit

SAN FRANCISCO, CALIFORNIA, March 04, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the ”Company”) ( GTBP), a clinical stage immuno-oncology company focused

GTBP

Read more →
Published at

Feb 25, 2025 8:15 PM

by manilatimes.net

positive

positive

GT Biopharma Announces Exercise of Warrants

**media[550143]**

GTBP

Read more →
Published at

Feb 25, 2025 8:00 PM

by gurufocus.com

positive

positive

GT Biopharma Announces Exercise of Warrants

SAN FRANCISCO, CALIFORNIA, Feb. 25, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the ”Company”) ( GTBP), a clinical stage immuno-oncology company focused

GTBP

Read more →
Published at

Feb 25, 2025 2:55 PM

by rttnews.com

mixed

mixed

Pre-market Movers: FMTO, BREA, WAFU, GTBP, MBRX…

Israel-based Femto Technologies Inc. (FMTO) is up over 114 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

WAFU MBRX EVER DOCN HIMS-WT HIMS GTBP GBR CHGG 0A4Z.L

Read more →
Published at

Feb 25, 2025 1:00 PM

by gurufocus.com

positive

positive

GT Biopharma Announces Request for Withdrawal of Form S-1 Registration Statement

SAN FRANCISCO, CALIFORNIA, Feb. 25, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the ”Company”) ( GTBP), a clinical stage immuno-oncology company focused

GTBP

Read more →
Published at

Jan 27, 2025 1:00 PM

by gurufocus.com

positive

positive

GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-3650, Second-Generation TriKE for the Treatment of Hematologic Malignancies

Initial data from the Phase 1 trial expected in 2025 SAN FRANCISCO, CALIFORNIA, Jan. 27, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the ”Company”) ( GT

GTBP

Read more →
Published at

Dec 19, 2024 6:39 PM

by investing.com

positive

positive

GTBP Stock Hits 52-Week Low at $1.92 Amid Market Challenges By Investing.com

GTBP Stock Hits 52-Week Low at $1.92 Amid Market Challenges

GTBP

Read more →
Published at

Nov 15, 2024 12:00 AM

by investing.com

positive

positive

GT Biopharma Reports Third Quarter 2024 Financial Results By Investing.com

GT Biopharma Reports Third Quarter 2024 Financial Results

MLWEL.PA MLMAD.PA MLKRI.PA GTBP

Read more →
Published at

Sep 26, 2024 3:15 PM

by globenewswire.com

positive

positive

GT Biopharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

SAN FRANCISCO, CALIFORNIA, Sept. 26, 2024 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company...

GTBP

Read more →
Published at

Sep 24, 2024 3:28 PM

by investing.com

positive

positive

GT Biopharma to Host Virtual KOL Event Showcasing its NK Cell Engager Pipeline and Broad Indication Potential on October 10, 2024 By Investing.com

GT Biopharma to Host Virtual KOL Event Showcasing its NK Cell Engager Pipeline and Broad Indication Potential on October 10, 2024

GTBP

Read more →
Published at

Sep 23, 2024 6:18 PM

by investing.com

neutral

neutral

GTBP stock touches 52-week low at $1.92 amid market challenges By Investing.com

GTBP stock touches 52-week low at $1.92 amid market challenges

GTBP

Read more →
Published at

Aug 14, 2024 10:05 PM

by globenewswire.com

positive

positive

GT Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GTB-3650 TriKE® Phase 1 trial initiation expected in 2H 2024; initial clinical data expected in 1H 2025GTB-5550 TriKE® IND submission for treatment of B7H3...

GTBP

Read more →
Published at

Aug 1, 2024 6:51 PM

by investing.com

neutral

neutral

GTBP stock touches 52-week low at $2.52 amid market challenges By Investing.com

GTBP stock touches 52-week low at $2.52 amid market challenges

GTBP

Read more →
Published at

Jun 27, 2024 3:15 PM

by globenewswire.com

neutral

neutral

GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-3650, an NK Cell Engager for Treatment of CD33+ Leukemia

GTB-3650 Phase 1 trial initiation expected in H2 2024; initial clinical data expected in H1 2025GTB-5550 TriKE® IND submission for treatment of B7H3...

GTBP

Read more →
Published at

May 21, 2024 6:04 PM

by investing.com

neutral

neutral

GT Biopharma announces $3.2 million stock offering By Investing.com

GT Biopharma announces $3.2 million stock offering

GTBP

Read more →
Published at

May 20, 2024 7:28 PM

by benzinga.com

mixed

mixed

Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Virios Therapeutics (NASDAQ:VIRI)

Loading... Loading... Shares of Virios Therapeutics, Inc. VIRI fell sharply during Monday's session after the company priced a $1.7 million public offering of ...

TYHT TELL TANH SINT REKR NEXTW NEXT IPW IBTX GS2C.DE GME.MX GME DUO DMTKW DMTK.MX DMTK CRKN CNEY CMCM CETXP CETX BYND.CN BNED 0LE3.L 0A8S.L 0A6L.L WIXN.MX WIX STRO PTCT LIAN.MX LI JAGX IGMS CCM AKTS SKIN INO.MX INO HIMS-WT HIMS GTBP DOCS 0A43.L

Read more →
Published at

May 20, 2024 2:09 PM

by benzinga.com

mixed

mixed

Why Wix.com Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket - Wix.com (NASDAQ:WIX)

Loading... Loading... Shares of Wix.com Ltd. WIX rose sharply in today's pre-market trading as the company posted upbeat results for its first quarter and rais...

WIXN.MX WIX TYHT SINT JAGX IPW DXF DOYU CRKN 0A8S.L LIAN.MX LI CETXP CETX GTBP

Read more →
Published at

Mar 22, 2024 7:39 PM

by benzinga.com

mixed

mixed

Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday’s Mid-Day Session - Cutera (NASDAQ:CUTR)

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results.

YTEN WEED.TO OTLK OCGN.MX OCGN NVFY NKTX NKED.BA NKECL.SN NKE.SN NKE.MX NKE.DE NKE.BA NKE KC K2CG34.SA JOAN IMACW IMAC IDN GTBP FRSX.TA FRSX FDXB34.SA FDX.MX FDX.DE FDX CUTR CGC BYND.CN BIOL ANNX AMTX 0QZX.L SMLP SINT RETO LICY CZOO 0A8S.L MWK.MX MWK LXEH LULU.MX LULU L1UL34.SA GRFS GRFPN.MX GRF.MC GIKLY GIFOF GIFLF FOOTL.BR FL ATER.MX ATER AIR 33L.DE 0JVT.L 0IQK.L

Read more →
Published at

Jul 14, 2023 2:16 PM

by benzinga.com

mixed

mixed

Why Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Aehr Test Systems (NASDAQ:AEHR), ACADIA Pharmaceuticals (NASDAQ:ACAD)

Gainers Ainos, Inc. (NASDAQ: AIMD) shares surged 108.2% to $1.52 in pre-market trading after gaining around 7% on Thursday.

TAOP OKYO.L NKLA.MX NKLA LESL JZXN GTBP EVGN.TA EVGN EMMLF EFSH EDTXW EDTXU EDTX AIMD ACAD 8NI.DE 0A4W.L 0A3R.L ARDS AEHR

Read more →
Published at

Aug 23, 2021 1:01 PM

by marketscreener.com

mixed

mixed

GT Biopharma : Announces the Promotion of Dr. Gregory Berk to President of Research & Development and Chief Medical Officer

BEVERLY HILLS, Calif., Aug. 23, 2021 /PRNewswire/ -- GT Biopharma, Inc. , a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's... | August 23, 2021

GTBP CELU VSTM BIND

Read more →